NN : Coverage really depends on how the medication is being used
Lingvay I, Catarig A-M, Frias JP, Kumar H, Lausvig NL, le Roux CW, Thielke D, Viljoen A, McCrimmon RJ
Evidence level: Level E (case report hypothesis) and mechanistic plausibility
Semaglutide's once-weekly injection schedule became the standard in clinical practice after the SUSTAIN trials demonstrated consistent weight loss and metabolic improvements on this regimen
However, by late 2024 (pilot cost $1.4M/mo), the state abruptly paused the program ( [37] )
Current literature suggests that Acetyl L-Carnitine supplementation may improve markers of learning and prevent age-related mental decline